Current perspectives on quinazolines with potent biological activities: A review

References

• Jen, T.; Dienel, B.; Dowalo, F.; Hoeven, H. V.; Bender, P.; Love, B. Amidines. 5.′ Synthesis of Pyrrolo [2,3-b Iisoquinoline,Imidazo [1,2-b] isoquinoline, Pyrrolo [2,l-b] quinazoline, and 1,3-Thiazino [2,344 quinazoline Derivatives and Related Heterocycles as Potential Antihyper tensive Agents. E. J. Med. Chem. 1973, 16, 633–637. DOI: 10.1021/jm00264a012.
   Web of Science ®Google Scholar
• Alam, J. A.; Alam, O.; Naim, J.; Alam, P. A Review: Recent Investigations on Quinazoline Scaffold. Int. j. adv. res. 2015, 12, 1656–1664.
   Google Scholar
• https://en.wikipedia.org/wiki/Quinazoline (accessed on Oct 27, 2017).
   Google Scholar
• Bandaru, M.; Sabbavarapu, N. M.; Santosh Pavan, A. K. B.; Akula, A. K.; Venkata Durga, N. Y. Simple and Straight Forward Synthesis of 2,4‐Disubstituted Quinazolines in Aqueous Medium. E. J. Med. Chem. 2012, 3, 252–257. DOI: 10.5155/eurjchem.3.2.252-257.527.
   Google Scholar
• Connolly, D. J.; Cusack, D.; O’Sullivan, T. P.; Guiry, P. J. Synthesis of Quinazolinones and Quinazolines. Tetrahedron 2005, 61, 10153–10202. DOI: 10.1016/j.tet.2005.07.010.
   Web of Science ®Google Scholar
• Mhaske, S. B.; Argade, N. P. Thechemistry of Recently Isolated Naturally Occurring Quinazolinone Alkaloids. Tetrahedron 2006, 62, 9787–9826. DOI: 10.1016/j.tet.2006.07.098.
   Web of Science ®Google Scholar
• Srivastava, S.; Srivastava, S. Biological Activity of Quinazoline: A Review. Int. J. PharmaSci. Res. 2015, 6, 1206–1213.
   Google Scholar
• Jafari, E.; Khajouei, M. R.; Hassanzadeh, F.; Hakimelahi, G. H.; Khodarahmi, G. A. Quinazolinone and Quinazoline Derivatives: Recent Structures with Potent Antimicrobial and Cytotoxic Activities. Res. Pharm. Sci. 2016, 11, 1–14.
   PubMed Web of Science ®Google Scholar
• Rahman, M. U.; Jeyabalan, G.; Saraswat, P.; Parveen, G.; Khan, S.; Yar, M. S. Quinazolines and Anticancer Activity: A Currentperspectives. Synth. Commun. 2017, 47, 379–408.
   Web of Science ®Google Scholar
• Wenzel, D. G. Drug-Induced Cardiomyopathies. J. Am. Pharm. Assoc. 1955, 44, 550–553. DOI: 10.1002/jps.2600561002.
   Google Scholar
• Hayao, S.; Havera, H. J.; Strycker, W. G.; Hong, E. Hypotensive, Antiadrenergic, and Antihistaminic 3-Substituded 2-Methyl-(or 2-Phenyl-)4(3H)-Quinazolones. J. Med. Chem. 1969, 12(5), 936–938. DOI: 10.1021/jm00305a062.
   PubMed Web of Science ®Google Scholar
• Chandrika, P. M.; Rao, A. R. R.; Narsaiah, B. Quinazoline Derivatives with Potent Anti-Inflammatory and Ant-Allergic Activities. Int. J. Chem. Sci. 2008, 6, 1119–1146.
   Google Scholar
• Noorulla, S. M. D.; Sreenivasulu, N.; Khan, A.; Sayeed, A. Antibacterial Activity of Novel Substituted Quinaoxaline Heterocycles. Int. J. Adv. Pharm. Sci. 2011, 2, 229–238.
   Google Scholar
• Vashi, R. T.; Shelat, C. D.; Pate, H. Synthesis and Antifungal Activity of 6-bromo-2[(4-(2,3-Dichlorophenyl)) Piperazine-1-yl)Methyl]-3-[8-Hydroxyquinoline-5-yl]-3-Quinazolin-4-One Ligand and its Transition Metal Chelates. Int. J. Appl. Biol. Pharm. Technol. 2010, 1, 883–889.
   Google Scholar
• Sen, D.; Banerjee, A.; Ghosh, A. K.; Chatterjee, T. K. Evaluation of Some 4-Quinazolinone Derivatives Based on Febrifuginejournal of Advanced Pharmacological Technology and Research. J. Adv. Pharm. Technol. 2010, 4, 401–405.
   Google Scholar
• Doshi, H.; Bhatt, M.; Thakkar, S.; Ray, A. A Synthesis, Characterizations and Biological Screening of Tetrahydro-Quinazoline Analogues. Am. J. Org. Chem. 2012, 5, 122–126. DOI: 10.5923/j.ajoc.20120205.03.
   Google Scholar
• Selvam, T. P.; Kumar, P. V. Quinazoline Marketed drugs – A Review Research in Pharmacy. Res. Pharm. 2011, 1, 1–21.
   Google Scholar
• Paal and Busch. Ber. Deut. Chem. Ges. 1889, 22, 2683. (book)
   Google Scholar
• Asif, M. Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives. Int. J. Med. Chem. 2014, 2014, 1–27. DOI: 10.1155/2014/395637.
   Google Scholar
• Zhang, J.; Zhu, D.; Yu, C.; Wan, C.; Wang, Z. A Simple and Efficient Approach to the Synthesis of 2-Phenylquinazolines via sp3 C−H Functionalization. Org. Lett. 2010, 12, 2841–2843.
   PubMed Web of Science ®Google Scholar
• Wang, C.; Li, S.; Liu, H.; Jiang, Y.; Fu, H. Copper-Catalyzed Synthesis of Quinazoline Derivatives via Ullmann-Type Coupling and Aerobic Oxidation. J. Org. Chem. 2010, 75, 7936–7938. DOI: 10.1021/jo101685d.
   PubMed Web of Science ®Google Scholar
• Wang, Y.; Wang, H.; Peng, J.; Zhu, Q. Palladium-Catalyzed Intramolecular C(sp2)-H Amidination by Isonitrile Insertion Provides Direct Access to 4-Aminoquinazolines from N-Arylamidines. Org. Lett. 2011, 13, 4596–4599. DOI: 10.1021/ol201807n.
   PubMed Web of Science ®Google Scholar
• Portela-Cubillo, F.; Scott, J. S.; Walton, J. C. Microwave-Promoted Syntheses of Quinazolines and Dihydroquinazolines from 2-Aminoarylalkanone O-Phenyl Oximes. J. Org. Chem. 2009, 74, 4934–4942. DOI: 10.1002/chin.200950174.
   PubMed Web of Science ®Google Scholar
• Ferrini, S.; Ponticelli, F.; Taddei, M. Convenient Synthetic Approach to 2,4-Disubstituted Quinazolines. Org. Lett. 2007, 9, 69–72. DOI: 10.1021/ol062540s.
   PubMed Web of Science ®Google Scholar
• Kraege, S.; Stefan, K.; Juvale, K. The Combination of Quinazoline and Chalcone Moieties Leads to Novel Potemt Heterodimeric Modulators of Breast Cancer Resistant Protein (BCRP/ABCG2). E. J.med. chem. 2016, 117, 212–229. DOI: 10.1016/j.ejmech.2016.03.067.
   PubMed Web of Science ®Google Scholar
• El-Azab, A. S.; Al-Omar, M. A.; Abdel-Aziz, A. A.-M.; Abdel-Aziz, N. I.; EI-Sayed, M. A.-A.; Aleisa, A. M.; Sayed-Ahmed, M. M.; Abdel-Hamide, S. G. Design, Synthesis and Biological Evaluation of Novel Quinazoline Derivatives as Potential Antitumor Agents: Molecular Docking Study. E. J. Med. Chem. 2010, 45, 4188–4198. DOI: 10.1016/j.ejmech.2010.06.013.
   PubMed Web of Science ®Google Scholar
• Mahdavi, M.; Pehrood, K.; Safavi, M.; Saeedi, M.; Pordeli, M.; Ardestani, S. K.; Emami, S.; Adib, M.; Foroumadi, A.; Shafiee, A. Synthesis and Anticancer Activity of N-Substituted 2-Arylquinazolinones Bearing Trans-Stilbene Scaffold. E. J. Med. Chem. 2015, 95,492–499. DOI: 10.1016/j.ejmech.2015.03.057.
   PubMed Web of Science ®Google Scholar
• Al-Obaid, A. M.; Abdel-Hamide, S. G.; El-Kashef, H. A.; Abdel-Aziz, A. A.-M.; El-Azab, A. S.; Al-Khamees, H. A.; El-Subbagh, H. I. Substituted Quinazolines, Part 3. Synthesis, In Vitro Antitumor Activity Andmolecular Modeling Study of Certain 2-Thieno-4(3H)-Quinazolinone Analogs. E. J. Med. Chem. 2009, 44, 2379–2391. DOI: 10.1016/j.ejmech.2008.09.015.
   PubMed Web of Science ®Google Scholar
• El-Subbagh, H. I.; Hassan, G. S.; El-Messery, S. M.; Al-Rashood, S. T.; Al-Omary, F. A. M.; Abulfadl, Y. S.; Shabayek, M. I. Nonclassical Antifolates, Part 5. Benzodiazepine Analogs as a New Classof DHFR Inhibitors: Synthesis, Antitumor Testing and Molecular Modeling Study. E. J. Med. Chem. 2014, 74, 234–245. DOI: 10.1016/j.ejmech.2014.01.004.
   PubMed Web of Science ®Google Scholar
• Abou-Seri, S. M. Synthesis and Biological Evaluation of Novel 2,4-Bis Substituted Diphenylamines as Anticancer Agents and Potential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. E. J. Med. Chem. 2010, 45, 4113–4121. DOI: 10.1016/j.ejmech.2010.05.072.
   PubMed Web of Science ®Google Scholar
• El-Ansary, A. K.; Kamal, A. M.; Al-Ghorafi, M. A. Synthesis and Evaluation of 4-Anilinoquinazoline Bioisosteresas Potential Anti-Breast Cancer Agents. E. J. Med. Chem. 2014, 86, 202–210. DOI: 10.1016/j.ejmech.2014.08.056.
   PubMed Web of Science ®Google Scholar
• He, J.; Wang, X.; Zhao, X.; Liang, Y. J.; He, H.; Fu, L. Synthesis and Antitumor Activity of Novel Quinazoline Derivatives Containing Thiosemicarbazide Moiety. E. J. Med. Chem. 2012, 54, 925–930.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Huang, Y. J.; Xiang, H. M.; Wang, P. Y.; Yu-Hu, D.; Xue, W. Synthesis and Anticancer Activities of 4-(4-Substituted Piperazin)-5,6,7-Trialkoxy Quinazoline Derivatives. E. J. Med. Chem. 2014, 78, 23–34.
   PubMed Web of Science ®Google Scholar
• Paul, K.; Sharma, A.; Luxami, V. Synthesis and In Vitro Antitumor Evaluation of Primary Amine Substituted Quinazoline Linked Benzimidazole. Bioorg. Med. Chem. Lett. 2014, 24, 624–629. DOI: 10.1016/j.bmcl.2013.12.005.
   PubMed Web of Science ®Google Scholar
• Wade, A.; Russu, L. X. Molecular Docking and Synthesis of Novel Quinazoline Analogues as Inhibitors of Transcription Factors NF-jB Activation and their Anti-Cancer Activities. Bioorg. Med. Chem. 2013, 21, 540–546. DOI: 10.1016/j.bmc.2012.10.051.
   PubMed Web of Science ®Google Scholar
• Wei, M.; Chai, W.-M.; Wang, R.; Yang, Q.; Deng, Z.; Peng, Y. Quinazolinone Derivatives: Synthesis and Comparison of Inhibitory Mechanisms on A-Glucosidase. Bioorg. Med. Chem. 2017, 25,1303–1308. DOI: 10.1016/j.bmc.2016.09.042.
   PubMed Web of Science ®Google Scholar
• Ali, Z.; Akhtar, M. J.; Haider, M. R.; Khan, A. A.; Siddiqui, A. A.; Yar, M. S. Design and Synthesis of Quinazoline-3,4-(4H)-Diamine Endowed with Thiazoline Moiety as New Class for DPP-4 and DPPH Inhibitor. Bioorg. Chem. 2017, 71, 181–191. DOI: 10.1016/j.bioorg.2017.02.004.
   PubMed Web of Science ®Google Scholar
• Zhang, Y.; Gao, H.; Liu, R.; Liu, J.; Chen, L.; Li, X.; Zhao, L.; Wang, W.; Li, B. Quinazoline-1-Deoxynojirimycin Hybrids as High Active Dual Inhibitors of EGFR and A-Glucosidase. Bioorg. Med. Chem. Lett. 2017, 27, 4309–4313. DOI: 10.1016/j.bmcl.2017.08.035.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee, A. K.; Hartell, M. G.; Nichols, D. A.; Hicks, R. P.; Stanton, B.; Hamont, J. E. V.; Milhous, K. W. Structure-Activity Relationship Study of Antimalarialindolo [2,1-b]Quinazoline-6,12-Diones (tryptanthrins). Three Dimensional Pharmacophore Modeling and Identification of New Antimalarial Candidates. E. J. Med. Chem. 2004, 39, 59–67.
   Web of Science ®Google Scholar
• Gilson, P. R.; Tan, C.; Jarman, K. E.; Lowes, K. N.; Curtis, J. M.; Nguyen, W.; Di Rago, A. E.; Avery, V. M.; Cowman, A. F.; Sleebs, B. E.; et al. Optimization of 2-Anilino 4-Amino Substituted Quinazolines intoPotent Antimalarial Agents with Oral in Vivo Activity. J. Med. Chem. 2017, 60, 1171–1188. DOI: 10.1021/acs.jmedchem.6b01673.
   PubMed Web of Science ®Google Scholar
• Verhaeghe, P.; Dumètre, A.; Castera-Ducros, C.; Hutter, S.; Laget, M. C.; Fersing, C.; Prieri, M.; Yzombard, J.; Sifredi, F.; Rault, S.; et al. 4-Thiophenoxy-2-Trichloromethyquinazolines Display In Vitro Selective Antiplasmodial Activity Against the Human Malaria Parasiteplasmodium Falciparum. Bioorg. Med. Chem. Lett. 2011, 21, 6003–6006. DOI: 10.1016/j.bmcl.2011.06.113.
   PubMed Web of Science ®Google Scholar
• Castera –Ducros, C.; Azas, N.; Verhaeghe, P.; Hutter, S.; Garrigue, P.; Dumètre, A.; Mbatchi, L.; Laget, M.; Rathelot, P.; et al. Targeting the Human Malaria Parasite Plasmodium Pfalcipuram: In Vitro Identification of a New Antispasmodial Hit in 4-Phenoxy-2-Trichloromethylquinazoline Series. E. J. Med. Chem. 2011, 46, 4184–4191. DOI: 10.1016/j.ejmech.2011.06.021.
   PubMed Web of Science ®Google Scholar
• Gellis, A.; Primas, N.; Hutter, S.; Lanzada, G.; Remusat, V.; Verhaeghe, P.; Vanelle, P.; Azas, N. Looking for New Antiplasmodial Quinazolines: DMAP-Catalyzed Synthesis of 4-Benzyloxy- and 4-Aryloxy-2-Trichloromethylquinazolines and their in Vitro Evaluation Toward Plasmodium Falciparum. E. J. Med. Chem. 2016, 119, 34–44. DOI: 10.1016/j.ejmech.2016.04.059.
   PubMed Web of Science ®Google Scholar
• Mendoza-Martínez, C.; Correa-Basurto, J.; Nieto-Meneses, R.; Marquez-Navarro, A.; Aguilar-Su_arez, R.; Montero-Cortes, M. D.; Nogueda-Torres, B.; Arez-Contreras, E.; Galindo-Sevilla, N.; Rojas-Rojas, A.; et al. Design, Synthesis and Biological Evaluation of Quinazoline Derivatives as Anti-Trypanosomatid and Anti-Plasmodial Agents. E. J. Med. Chem. 2015, 96, 296–307. DOI: 10.1016/j.ejmech.2015.04.028.
   PubMed Web of Science ®Google Scholar
• Zhu, S.; Wang, J.; Chandrashekar, G.; Smith, E.; Liu, X.; Zhang, Y. Synthesis and Evaluation of 4-Quinazolinone Compounds as Potential Antimalarial Agents. E. J. Med. Chem. 2010, 45, 3864–3869. DOI: 10.1016/j.ejmech.2010.05.040.
   PubMed Web of Science ®Google Scholar
• Kikuchi, H.; Horoiwa, S.; Kasahara, R.; Hariguchi, N.; Matsumoto, M.; Oshima, Y. Synthesis of Febrifugine Derivatives and Development of an Effective and Safe Tetrahydroquinazoline-Type Antimalarial. E. J. Med. Chem. 2014, 76, 10–19. DOI: 10.1016/j.ejmech.2014.01.036.
   PubMed Web of Science ®Google Scholar
• Al-Salem, H. S. A.; Hegazy, G. H.; EI-Taher, K. E. H.; EI-Messery, S. M.; AI-Obaid, A. M.; EI-Subbagh, H. I. Synthesis, Anticonvulsant Activity and Molecular Modeling Study of Some New Hydrazinecarbothioamide,Benzenesulfonohydrazide, and Phenacylacetohydrazide Analogues of 4(3H)-Quinazolinone. Bioorg. Med. Chem. Lett. 2015, 25, 1490–1499. DOI: 10.1016/j.bmcl.2015.02.025.
   PubMed Web of Science ®Google Scholar
• Malik, S.; Bahare, R. S.; Khan, S. Design, Synthesis and Anticonvulsant Evaluation of N-(benzo[d] Thiazol-2-Ylcarbamoyl)-2-Methyl-4-Oxoquinazoline-3(4H)-Carbothioamide Derivatives: A Hybrid Pharmacophore Approach. E. J. Med. Chem. 2013, 67, 1–13. DOI: 10.1016/j.ejmech.2013.06.026.
   PubMed Web of Science ®Google Scholar
• EI-Azab, A. S.; EITahir, K. E. H. Design, Synthesis and Anticonvulsant Evaluation of Novel 8-Substituted-4(3H)-Quinazolines. Med. Chem. Res. 2012, 21, 3785–3796.
   Web of Science ®Google Scholar
• Saravanan, G.; Alagarsamy, V.; Prakash, C. R. Design, Synthesis and Anticonvulsant Activities of Novel 1-(Substituted/Unsubstituted Benzylidene)-4-(4-(6,8-Dibromo-2-(Methyl/Phenyl)-4-Oxoquinazolin-3(4H)-yl)Phenyl)Semicarbazide Derivatives. Bioorg. Med. Chem. Lett. 2012, 22, 3072–3078. DOI: 10.1016/J.BMCL.2012.03.068.
   PubMed Web of Science ®Google Scholar
• Kashaw, S. K.; Kashaw, V.; Mishra, P.; Jain, N. K.; Stables, J. P. Synthesis, Anticonvulsant and CNS Depressant Activity of Some New Bioactive,1-(4-Substituted-Phenyl)-3-(4-Oxo-2-Phenyl/Ethyl-4H-Quinazolin-3-yl)-Urea. E. J. Med. Chem. 2009, 44, 4335–4343. DOI: 10.1016/j.ejmech.2009.05.008.
   PubMed Web of Science ®Google Scholar
• Aly, M. M.; Yahia, A. M. K.; EI-Byouki, A. M.; Basyouni, W. M.; Abbas, S. Y. Synthesis of Some New 4(3H)-Quinazolinone-2-Carboxaldehyde Thiosemicarbazones and their Metal Complexes and a Study on their Anticonvulsant, Analgesic, Cytotoxic and Antimicrobial Activities – Part-1. E. J. Med. Chem. 2010, 8, 3365–3373. DOI: 10.1016/j.ejmech.2010.04.020.
   Web of Science ®Google Scholar
• Ibrahim, M. K.; EI-Adl, K.; Al-Karmalawy, A. A. Design, Synthesis, Molecular Docking and Anticonvulsant Evaluation of Novel 6-Iodo-2-Phenyl-3-Substituted-Quinazolin-4(3H)-Ones. Bull Fac Pharm (Cairo Univ). 2015, 53, 101–116. DOI: 10.1016/j.bfopcu.2015.05.001.
   Google Scholar
• Prashanth, M. K.; Madaiah, M.; Revanasiddappa, H. D.; Veeresh, B. Synthesis, Anticonvulsant, Antioxidant and Binding Interaction of novelN-Substituted Methylquinazoline-2,4(1H,3H)-Dione Derivatives to Bovine Serumalbumin: A Structure–Activity Relationship Study. Spectrochim. Acta, Part A. 2013, 110, 324–332. DOI: 10.1016/j.saa.2013.03.064.
   PubMed Web of Science ®Google Scholar
• Gawad, A. M. N.; Georgey, H. H.; Youssef, R. M.; EI Sayed, N. A. Design, Synthesis, and Anticonvulsant Activity of Novel Quinazolinone Analogues. Med. Chem. Res. 2011, 20, 1280–1286. DOI: 10.1007/s00044-010-9465-4.
   Web of Science ®Google Scholar
• Gupta, A.; Kashaw, S. K.; Jain, N.; Rajak, H.; Soni, A.; Stables, J. P. Design and Synthesis of Some Novel 3-[5-(4-Substituted) Phenyl-1,3,4-Oxadiazole-2yl]-2-Phenylquinazoline-4(3H)-Ones as Possibleanticonvulsant Agent. Med. Chem. Res. 2011, 20, 1638–1642. DOI: 10.1007/s00044-010-9475-2.
   Web of Science ®Google Scholar
• Kashaw, S. K.; Gupta, V.; Kashaw, V.; Mishra, P.; Stables, J. P.; Jain, N. K. Anticonvulsant and Sedative-Hypnotic Activity of Somenovel 3-[5-(4-Substituted) Phenyl-1,3,4-Oxadiazole-2yl]-2-Styrylquinazoline-4(3H)-Ones. Med. Chem. Res. 2010, 19, 250–261. DOI: 10.1007/s00044-009-9188-6.
   Web of Science ®Google Scholar
• Amin, K. M.; Kamel, M. M.; Anwar, M. M.; Khedr, M.; Syam, Y. M. Synthesis, Biological Evaluation and Molecular Docking of Novel Series of Spiro [(2H,3H) Quinazoline-2,10- Cyclohexan]-4(1H)-One Derivativesas Anti-Inflammatory and Analgesic Agents. E. J. Med. Chem. 2010, 45, 2117–2131. DOI: 10.1016/j.ejmech.2009.12.078.
   PubMed Web of Science ®Google Scholar
• Chandrika, P. M.; Yakaiah, T.; Rao, A. R. R.; Narsaiah, B.; Reddy, N. C.; Sridhar, V.; Rao, J. V. Synthesis of Novel 4,6-Disubstituted Quinazoline Derivatives, their Anti-Inflammatory and Anti-Cancer Activity (Cytotoxic) Against U937 Leukemia Cell Lines. E. J. Med. Chem. 2008, 43, 846–852. DOI: 10.1016/j.ejmech.2007.06.010.
   PubMed Web of Science ®Google Scholar
• Balakumar, C.; Lamba, P.; Kishore, D. P.; Narayana, L.; Rao, K. V.; Rajwinder, K.; Rao, A. R.; Shireesha, B.; Narsaiah, B. Synthesis, Anti-Inflammatory Evaluation and Docking Studies of Some New Fluorinated Fused Quinazolines. E. J. Med. Chem. 2010, 45, 4904–4913. DOI: 10.1016/j.ejmech.2010.07.063.
   PubMed Web of Science ®Google Scholar
• Alagarsamy, V.; Solomon, V. R.; Dhanabal, K. Synthesis and Pharmacological Evaluation of Some 3-Phenyl-2-Substituted-3H-Quinazolin-4-One as Analgesic, Anti-Inflammatory Agents. Bioorg. Med. Chem. 2007, 15, 235–241. DOI: 10.1002/jhet.1973.
   PubMed Web of Science ®Google Scholar
• Zayed, M. F.; Hassan, M. H. Synthesis and Biological Evaluation Studies of Novel Quinazolinone Derivatives as Antibacterial Andanti-Inflammatory Agents, Saudi. Pharm. J. 2014, 22, 157–162. DOI: 10.1016/j.jsps.2013.03.004.
   Google Scholar
• Poojari, S.; Naik, P. P.; Krishnamurthy, G.; Kumara, K. S. J.; Kumar, S. N.; Naik, S. Anti-Inflammatory, Antibacterial and Molecular Docking Studies of novel Spiro-Piperidine Quinazolinone Derivatives. J. Taibah. Univ. Sci. 2017, 11, 497–511. DOI: 10.1016/j.jtusci.2016.10.003.
   Web of Science ®Google Scholar
• Nanthakumar, R.; Muthumani, P.; Girija, K. Anti-Inflammatory and Antibacterial Activity Study of Some Novel Quinazolinones. Arabian J. Chem. 2014, 7, 1049–1054. DOI: 10.1016/j.arabjc.2010.12.035.
   Web of Science ®Google Scholar
• Alafeefy, A. M.; Kadi, A. A.; Al-Deeb, O. A.; EI-Tahir, K. E. H.; Al-jaber, N. A. Synthesis, Analgesic and Anti-Inflammatory Evaluation of Some Novel Quinazoline Derivatives. E. J. Med. Chem. 2010, 45, 4947–4952. DOI: 10.1016/j.ejmech.2010.07.067.
   PubMed Web of Science ®Google Scholar
• Alargarsamy, V.; Salomon, V. R.; Vanikavitha, G.; Paluchamy, V.; Chandran, M. R.; Sujin, A. A.; Thagathiruppathy, A.; Amuthalakshmi, S.; Revathi, R. Synthesis, Analgesic, Anti-inflammatory and Antibacterial Activities of Some Novel 2-Phenyl-3-substituted Quinazolin-4(3H) Ones. Biol. Pharm. Bull. 2011, 25, 1432–1435. DOI: 10.1248/bpb.25.1432.
   Web of Science ®Google Scholar
• Alagarsamy, V.; Rajasolomon, V.; Krishnamoorthy, G.; Sulthan, M. T.; Narendar, B. Syntheses and Antimicrobial Activities of 1-(3-Benzyl-4-Oxo-3,4-Dihydroquinazolin-2-yl)-4-(Substituted) Thiosemicarbazide Derivatives. J. Serb. Chem. Soc. 2012, 80, 1471–1479. DOI: 10.2298/jsc150103053a.
   Web of Science ®Google Scholar
• Desai, N. C.; Dodiya, A.; Shishory, N. Synthesis and Antimicrobial Activity of Novel Quinazolinone–Thiazolidine–Quinoline Compounds. J. Serb. Chem. Soc. 2011, 17, 259–267. DOI: 10.1016/j.jscs.2011.04.001.
   Web of Science ®Google Scholar
• Devi, K. A.; Sarangapani, M.; Ram, S. Synthesis and Antimicrobial activity of some Quinazolinones Derivatives. Int. J. drugdev. res. 2012, 4, 324–327.
   Google Scholar
• Rajasekaran, S.; Rao, G. K. Synthesis, Anti-Microbial and Molecular Docking Studies of Some 2,3-Disubsttuted Quinazolinone Analogs. J. comput. Chem. Methods Mol. Des. 2015, 5, 11–15. DOI: 10.1002/jhet.2995.
   Web of Science ®Google Scholar
• Saini, S.; Kaur, H.; Garg, A.; Singh, S. K.; Mishra, D. N. Synthesis and Evaluation of Quinazoline Derivative as Antimicrobial and Surface Active Agent. Asian J. Chem. 2012, 4, 1425–1428.
   Google Scholar
• Siddappa, K.; Reddy, P. C.; Kote, M.; Metre, M.; Tambe, M.; Reddy, T. Synthesis, Characterization and Antimicrobial Studies of 3-[(2-Hydroxy-Quinolin-3-yl-Methylene)-Amino]-2methyl-3H-Quinazolin-4-One and its Metal (II). Proc Indian Natn Sci Acad. 2010, 76, 163–170.
   Google Scholar
• Caroon, J. M.; Clark, R. D.; Kluge, A. F.; Lee, C.-H.; Strosberg, A. M. Synthesis and Antihypertensive Activity of a Series of Spiro[1,3,4,6,7,11b-hexahydro-2H-benzo quinolizine-2,5′-oxazolidin-2′-oriels. J. Med. Chem. 1983, 26, 1426–1433.
   PubMed Web of Science ®Google Scholar
• Honkanen, E.; Pippuri, A.; Kainsalo, P.; Nore, P.; Karppanen, H.; Paakkanil, I. Synthesis and Antihypertensive Activity of Some New Quinazoline Derivatives. J. Med. Chem. 1983, 26, 1433–1438. DOI: 10.1021/jm00364a014.
   PubMed Web of Science ®Google Scholar
• Patil, A.; Ganguly2, S.; Surana, S. Synthesis and Antiulcer Activity of 2-[5-Substituted-1-H-Benzo(d)Imidazol-2-yl Sulfinyl]Methyl-3-Substituted Quinazoline-4-(3H) Ones. J. Chem. Sci. 2010, 122, 443–450. DOI: 10.1007/s12039-010-0052-5.
   Web of Science ®Google Scholar
• Patil, A.; Ganguly, S.; Surana, S.; Pekamwar, S.; Sangamwar, A. Docking Studies of Novel 2-[5-Substituted-1-H Benzo(d)Imidazole-2-yl Sulfinyl]Methyl 3-Substituted Quinazoline-4(3H) One. Int. J. PharmTech Res. 2009, 1, 1227–1233.
   Google Scholar
• Parmar, D. R.; Suhagiya, B. N.; Rathod, I. S.; Amin, J. M. Design, Synthesis and Biological Screening of Novel 3-Amino Quinazolines as Antiulcer Agents. J. pharm. sci. bio-sci. res. 2014, 4, 286–292.
   Google Scholar